MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2	https://doi.org/10.1186/1476-4598-9-83	2010	Cell line 2 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-27b targets PPAR? to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells	https://doi.org/10.1038/onc.2011.543	2012	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells	https://doi.org/10.1158/1535-7163.MCT-12-0001	2012	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A	https://doi.org/10.1002/ijc.28091	2013	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
"miR-200a Inhibits Tumor Proliferation by Targeting AP-2? in Neuroblastoma Cells"	https://doi.org/10.7314/apjcp.2014.15.11.4671	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells	https://doi.org/10.3892/ol.2018.9431	2018	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor	https://doi.org/10.3892/mmr.2016.4770	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1	https://doi.org/10.1186/1476-4598-12-23	2013	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis	https://doi.org/10.1158/0008-5472.CAN-06-3667	2007	Cell line 2 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1	https://doi.org/10.3892/etm.2019.8007	2019	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
The MYCN oncogene is a direct target of miR-34a	https://doi.org/10.1038/onc.2008.154	0	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-223-3p promotes the growth and invasion of neuroblastoma cell via targeting FOXO1	https://doi.org/10.26355/eurrev_201910_19298	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness	https://doi.org/10.1096/fj.09-134965	2009	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo	https://doi.org/10.1016/j.yexcr.2013.02.025	2013	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs	https://doi.org/10.1038/onc.2012.311	2013	Cell line 2 Master/Detail View	Cell line and drug 4 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs	https://doi.org/10.1038/onc.2012.490	2013	Cell line 0 Master/Detail View	Cell line and drug 4 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF)	https://doi.org/10.1038/onc.2012.490	2011	Cell line 0 Master/Detail View	Cell line and drug 4 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma	https://doi.org/10.1093/nar/gkt346	2013	Cell line 0 Master/Detail View	Cell line and drug 15 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells	https://doi.org/10.1016/j.biopha.2017.07.158	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-590-5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5	https://doi.org/10.3892/mmr.2018.9173	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications